Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.470
+0.060 (1.76%)
At close: Feb 21, 2025, 4:00 PM
3.310
-0.160 (-4.61%)
After-hours: Feb 21, 2025, 5:57 PM EST
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $5.06 million as of February 21, 2025. Its market cap has increased by 87.44% in one year.
Market Cap
5.06M
Enterprise Value
1.74M
1-Year Change
87.44%
Ranking
Category
Stock Price
$3.47
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $161.90M to $5.06M, a decrease of -96.87%. That is a compound annual growth rate of -33.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 5.10M | 131.82% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.43% |
| Dec 31, 2021 | 38.60M | -74.59% |
| Dec 31, 2020 | 151.90M | 413.18% |
| Dec 31, 2019 | 29.60M | 2.78% |
| Dec 31, 2018 | 28.80M | -68.28% |
| Dec 29, 2017 | 90.80M | 83.81% |
| Dec 30, 2016 | 49.40M | -69.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |